SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-024341
Filing Date
2023-05-26
Accepted
2023-05-26 08:01:08
Documents
12
Period of Report
2023-05-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rapt-20230524.htm   iXBRL 8-K 77922
  Complete submission text file 0000950170-23-024341.txt   195436

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rapt-20230524_pre.xml EX-101.PRE 9832
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rapt-20230524_lab.xml EX-101.LAB 13350
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rapt-20230524.xsd EX-101.SCH 2457
6 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20230524_htm.xml XML 4713
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38997 | Film No.: 23963112
SIC: 2834 Pharmaceutical Preparations